Pharus SICAV - Medical Innovation Class A EUR Acc

Pharus SICAV Medical Innovation aims to grow by primarily investing in the stocks of pioneering biopharmaceutical companies driving medical advancements. The fund dedicates at least two-thirds of its assets to equities from innovative firms, mainly located in North America and Western Europe, where the pharmaceutical sector is particularly strong. To ensure diversification, it also includes government and corporate bonds and allocates up to 10% of its portfolio to exchange-traded funds and other similar investment vehicles.